logo
Select company
Select metric
$ -47.3MConsolidated Income
VS
Market
20
Sector
40
Industry
51
History
9
$ 10.65Close
$ 2.49 - $ 10.69 52-Week Range
Ticker Information

Ticker

TRVI

Company Name

TREVI THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TREVI THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TRVI - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -47.3M
3/31/2025$ -47.35M
12/31/2024$ -47.91M
9/30/2024$ -44.32M
6/30/2024$ -38.77M
3/31/2024$ -33.57M
12/31/2023$ -29.07M
9/30/2023$ -26.75M
6/30/2023$ -27.32M
3/31/2023$ -28.22M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TREVI THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -29.77M.
  • Over the past 5 years, TREVI THERAPEUTICS INC's average Cons. Inc. has been $ -34.75M.
  • The median Cons. Inc. for TREVI THERAPEUTICS INC during this period was $ -32.83M
  • TREVI THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -26.75M.
  • The lowest Cons. Inc. recorded by TREVI THERAPEUTICS INC in the same timeframe $ -47.91M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

TRVI - Consolidated Income, Last 5 years

$ -47.91M

Minimum

Dec 31, 2024

$ -26.75M

Maximum

Sep 30, 2023

$ -34.75M

Average

$ -32.83M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.01M with a standard deviation of $ 116.51M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.01M
median$ -2.1M
std$ 116.51M